AGN 196996RARαantagonist CAS# 958295-17-5 |
2D Structure
- AM580
Catalog No.:BCC5373
CAS No.:102121-60-8
- AGN 194310
Catalog No.:BCC5416
CAS No.:229961-45-9
- Palovarotene
Catalog No.:BCC4185
CAS No.:410528-02-8
- AGN 205728
Catalog No.:BCC5418
CAS No.:859498-05-8
- AGN 196996
Catalog No.:BCC5417
CAS No.:958295-17-5
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 958295-17-5 | SDF | Download SDF |
PubChem ID | 24785198 | Appearance | Powder |
Formula | C24H20BrNO5 | M.Wt | 482.32 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 4-[[3-bromo-4-ethoxy-5-(4-methylbenzoyl)benzoyl]amino]benzoic acid | ||
SMILES | CCOC1=C(C=C(C=C1Br)C(=O)NC2=CC=C(C=C2)C(=O)O)C(=O)C3=CC=C(C=C3)C | ||
Standard InChIKey | BUGXGZOGQGUTBC-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C24H20BrNO5/c1-3-31-22-19(21(27)15-6-4-14(2)5-7-15)12-17(13-20(22)25)23(28)26-18-10-8-16(9-11-18)24(29)30/h4-13H,3H2,1-2H3,(H,26,28)(H,29,30) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | AGN 196996 is a potent and selective RARα antagonist with Ki value of 2 nM; little binding affinity for RARβ(Ki=1087 nM) and RARγ(Ki=8523 nM).
IC50 value: 2 nM(Ki)
Target: RARα antagonist
AGN 196996 shows no activity in transactivation assays, but instead block the gene transcriptional activity induced by ATRA and other RAR agonists. References: |
AGN 196996 Dilution Calculator
AGN 196996 Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.0733 mL | 10.3666 mL | 20.7331 mL | 41.4662 mL | 51.8328 mL |
5 mM | 0.4147 mL | 2.0733 mL | 4.1466 mL | 8.2932 mL | 10.3666 mL |
10 mM | 0.2073 mL | 1.0367 mL | 2.0733 mL | 4.1466 mL | 5.1833 mL |
50 mM | 0.0415 mL | 0.2073 mL | 0.4147 mL | 0.8293 mL | 1.0367 mL |
100 mM | 0.0207 mL | 0.1037 mL | 0.2073 mL | 0.4147 mL | 0.5183 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
AGN 196996 is a specific antagonist of RARα with a Ki value of 2 nM [1].
AGN 196996 has been reported to selectively bind to RARs (retinoic acid receptors) with Ki values of 2 nM, 1087 nM and 8523 nM for RARα, RARβ and RARγ, respectively. In addition, AGN 196996 can inhibit the gene transcription activity which induced by ATRA and other RAR agonists. In LNCaP cell lines, AGN 196996 shown the activity of antagonist with an IC50 value of 1.8±0.3 μM, which is similar to normal prostate epithelial cell lines [1].
References:
[1] Keedwell RG1, Zhao Y, Hammond LA, Wen K, Qin S, Atangan LI, Shurland DL, Wallace DM, Bird R, Reitmair A, Chandraratna RA, Brown G. An antagonist of retinoic acid receptors more effectively inhibits growth of human prostate cancer cells than normal prostate epithelium. Br J Cancer. 2004 Aug 2;91(3):580-8.
- CPI-613
Catalog No.:BCC2287
CAS No.:95809-78-2
- MPC-3100
Catalog No.:BCC2128
CAS No.:958025-66-6
- HIV-1 integrase inhibitor 2
Catalog No.:BCC1619
CAS No.:957890-42-5
- Fmoc-Phe(4-NH2)-OH
Catalog No.:BCC3154
CAS No.:95753-56-3
- Fmoc-Phe(4-NO2)-OH
Catalog No.:BCC3277
CAS No.:95753-55-2
- Charybdotoxin
Catalog No.:BCC6933
CAS No.:95751-30-7
- FPH2 (BRD-9424)
Catalog No.:BCC5451
CAS No.:957485-64-2
- Nedaplatin
Catalog No.:BCC4807
CAS No.:95734-82-0
- Daphnodorin B
Catalog No.:BCN7937
CAS No.:95733-02-1
- Hedyotisol A
Catalog No.:BCN4508
CAS No.:95732-59-5
- BTZ043 Racemate
Catalog No.:BCC2488
CAS No.:957217-65-1
- NVP-QAV-572
Catalog No.:BCC4181
CAS No.:957209-68-6
- Piperlotine D
Catalog No.:BCN6494
CAS No.:958296-13-4
- Hedyotisol B
Catalog No.:BCN4752
CAS No.:95839-45-5
- Ipsapirone
Catalog No.:BCC7201
CAS No.:95847-70-4
- Momordin II
Catalog No.:BCN3473
CAS No.:95851-41-5
- Momordin IIa
Catalog No.:BCN3474
CAS No.:95851-50-6
- (E)-1-(4-Hydroxyphenyl)dec-1-en-3-one
Catalog No.:BCN4031
CAS No.:958631-84-0
- SID 26681509
Catalog No.:BCC2362
CAS No.:958772-66-2
- GSK1059615
Catalog No.:BCC4984
CAS No.:958852-01-2
- 12-Hydroxy-8(17),13-labdadien-16,15-olide
Catalog No.:BCN1298
CAS No.:958885-86-4
- Sotalol hydrochloride
Catalog No.:BCC5165
CAS No.:959-24-0
- 2-Benzoylacetanilide
Catalog No.:BCC8560
CAS No.:959-66-0
- A922500
Catalog No.:BCC2333
CAS No.:959122-11-3
Complexes of DNA bases and Watson-Crick base pairs interaction with neutral silver Agn (n = 8, 10, 12) clusters: a DFT and TDDFT study.[Pubmed:28325114]
J Biomol Struct Dyn. 2018 Mar;36(4):1050-1062.
We study the binding of the neutral Agn (n = 8, 10, 12) to the DNA base-adenine (A), guanine (G) and Watson-Crick -adenine-thymine, guanine-cytosine pairs. Geometries of complexes were optimized at the DFT level using the hybrid B3LYP functional. LANL2DZ effective core potential was used for silver and 6-31 + G(**) was used for all other atoms. NBO charges were analyzed using the Natural population analysis. The absorption properties of Agn-A,G/WC complexes were also studied using time-dependent density functional theory. The absorption spectra for these complexes show wavelength in the visible region. It was revealed that silver clusters interact more strongly with WC pairs than with isolated DNA complexes. Furthermore, it was found that the electronic charge transferred from silver to isolated DNA clusters are less than the electronic charge transferred from silver to the Agn-WC complexes. The vertical ionization potential, vertical electron affinity, hardness, and electrophilicity index of Agn-DNA/WC complexes have also been discussed.
Decursin in Angelica gigas Nakai (AGN) Enhances Doxorubicin Chemosensitivity in NCI/ADR-RES Ovarian Cancer Cells via Inhibition of P-glycoprotein Expression.[Pubmed:27605402]
Phytother Res. 2016 Dec;30(12):2020-2026.
Angelica gigas Nakai (AGN, Korean Dang-gui) is traditionally used for the treatment of various diseases including cancer. Here, we investigated multidrug-resistant phenotype-reversal activities of AGN and its compounds (decursin, ferulic acid, and nodakenin) in doxorubicin-resistant NCI/ADR-RES ovarian cancer cells. Our results showed that a combination of doxorubicin with either AGN or decursin inhibited a proliferation of NCI/ADR-RES cells. These combinations increased the number of cells at sub-G1 phase when cells were stained with Annexin V-fluorescein isothiocyanate. We also found that these combinations activated caspase-9, caspase-8, and caspase-3 and increased cleaved PARP level. Moreover, an inhibition of P-glycoprotein expression by either AGN or decursin resulted in a reduction of its activity in NCI/ADR-RES cells. Therefore, our data demonstrate that decursin in AGN inhibits doxorubicin-resistant ovarian cancer cell proliferation and induces apoptosis in the presence of doxorubicin via blocking P-glycoprotein expression. Therefore, AGN would be a potentially novel treatment option for multidrug-resistant tumors by sensitizing to anticancer agents. Copyright (c) 2016 John Wiley & Sons, Ltd.
Anti-cancer and other bioactivities of Korean Angelica gigas Nakai (AGN) and its major pyranocoumarin compounds.[Pubmed:22583405]
Anticancer Agents Med Chem. 2012 Dec;12(10):1239-54.
Korean Angelica gigas Nakai (AGN) is a major medicinal herb used in Asian countries such as Korea and China. Traditionally, its dried root has been used to treat anemia, pain, infection and articular rheumatism in Korea, most often through boiling in water to prepare the dosage forms. The pyranocoumarin compound decursin and its isomer decursinol angelate (DA) are the major chemical components in the alcoholic extracts of the root of AGN. The in vitro anti-tumor activities of decursin and/or DA against prostate cancer, lung cancer, breast cancer, colon cancer, bladder cancer, sarcoma, myeloma and leukemia have been increasingly reported in the past decade whereas the in vivo efficacy in mouse models was established only for a few organ sites. Preliminary pharmacokinetic studies by us and others in rodent models indicated that decursinol (DOH), which has much less in vitro direct anticancer activities by itself, is the major and rapid in vivo hydrolysis metabolite of both decursin and DA. Besides decursin, DA and DOH, other chemical components in AGN such as polysaccharides and polyacetylenes have been reported to exert anti-cancer and anti-inflammation activities as well. We systematically reviewed the published literature on the anti-cancer and other bio-activities effects of AGN extract and decursin, DA and DOH, as well as other chemicals identified from AGN. Although a number of areas are identified that merit further investigation, one critical need is first-in-human studies of the pharmacokinetics of decursin/DA to determine whether humans differ from rodents in absorption and metabolism of these compounds.
Usefulness of Chromogenic CromoCen(R) AGN agar medium for the identification of the genus Aeromonas: Assessment of faecal samples.[Pubmed:22561188]
J Microbiol Methods. 2012 Aug;90(2):100-4.
Selective screening media for the detection and identification of Aeromonas strains are needed to guide primary isolation procedures in the clinical laboratory. This study compared the selective CromoCen(R) AGN chromogenic agar medium for the detection and identification of Aeromonas strains that were isolated from various samples against the conventional selective agar media that are commonly used for the isolation of this organism in food, environmental and clinical samples. The Miles and Misra and ecometric methods were used to evaluate the microbiological performance of CromoCen(R) AGN chromogenic agar medium, which was shown to be satisfactory. A total of 14 reference Aeromonas strains, 44 wild strains and 106 clinical stool specimens were examined using both non-chromogenic selective agars that are commonly used for Aeromonas isolation and CromoCen(R) AGN agar. The latter exhibited 94.73% sensitivity and 100% specificity for the various samples. On CromoCen(R) AGN agar medium, Aeromonas formed colonies with light green, greenish and salmon pigments with or without a surrounding wide transparent zone (halo) of 2-3mm in diameter around the entire border. This medium is recommended for the isolation and potential identification of the Aeromonas genus.